HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 56 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $24,000 | -53.8% | 72,858 | +0.0% | 0.01% | -50.0% |
Q2 2020 | $52,000 | +116.7% | 72,850 | +0.0% | 0.02% | +100.0% |
Q1 2020 | $24,000 | -50.0% | 72,849 | +8.9% | 0.01% | -35.3% |
Q4 2019 | $48,000 | +4.3% | 66,900 | 0.0% | 0.02% | -5.6% |
Q3 2019 | $46,000 | -58.6% | 66,900 | 0.0% | 0.02% | -64.0% |
Q2 2019 | $111,000 | -30.2% | 66,900 | +5.0% | 0.05% | -51.5% |
Q1 2019 | $159,000 | -11.2% | 63,724 | -14.4% | 0.10% | +18.4% |
Q4 2018 | $179,000 | -41.9% | 74,420 | +6.5% | 0.09% | -47.3% |
Q3 2018 | $308,000 | +124.8% | 69,900 | +83.9% | 0.16% | +166.1% |
Q2 2018 | $137,000 | -50.0% | 38,000 | -50.0% | 0.06% | -23.5% |
Q1 2018 | $274,000 | – | 76,000 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 1,280,185 | $5,582,000 | 0.54% |
Cormorant Asset Management, LP | 201,000 | $876,000 | 0.10% |
PUTNAM INVESTMENTS LLC | 575,692 | $2,510,000 | 0.01% |
Alyeska Investment Group, L.P. | 89,722 | $391,000 | 0.00% |
BLACKROCK ADVISORS LLC | 463,200 | $2,020,000 | 0.00% |
Sonora Investment Management, LLC | 1,500 | $7,000 | 0.00% |
SECURIAN ASSET MANAGEMENT, INC | 14,008 | $61,000 | 0.00% |
MACKENZIE FINANCIAL CORP | 29,208 | $127,000 | 0.00% |
Tower Research Capital LLC (TRC) | 336 | $1,000 | 0.00% |
MORGAN STANLEY | 12 | $0 | 0.00% |